Measuring oral COVID-19 antiviral effectiveness using linked Australian data: Challenges and opportunities
Journal of Infection and Public Health · 2026-07 · 19 (7) · 103247
DOI: 10.1016/j.jiph.2026.103247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2026-07. Verfasst von Parveen Fathima und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Immunisation Research and Surveillance, New South Wales, Australia; Sydney School of Public Health, University of Sydney, New Sou…. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment, Ritonavir, COVID-19. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government Department of Health Disability and Ageing, Department of Health, State Government of Victoria.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Centre for Immunisation Research and Surveillance, New South Wales, Australia; Sydney School of Public Health, University of Sydney, New South Wales, Australia; Sydney Infectious Diseases Institute (Sydney ID),…
- National Centre for Immunisation Research and Surveillance, New South Wales, Australia.
- Infectious Diseases, Monash Health and School of Clinical Sciences, Monash University, Victoria, Australia.
- School of Population Health, University of New South Wales, New South Wales, Australia.
- Community and Public Health, Department of Health, Victoria, Australia.
- Department of Health Sciences, Macquarie University, New South Wales, Australia; Health Protection, NSW Ministry of Health, New South Wales, Australia.
Förderung
- Australian Government Department of Health Disability and Ageing
- Department of Health, State Government of Victoria
Zitieren
APA
Fathima, P., Scaria, A., Stepien, S., Cheng, A. C., Edwards, L. J., Robinson, E. J., Sumpton, C., Amin, J., & Liu, B. (2026). Measuring oral COVID-19 antiviral effectiveness using linked Australian data: Challenges and opportunities. Journal of Infection and Public Health, 19(7), 103247. https://doi.org/10.1016/j.jiph.2026.103247
Vancouver
Fathima P, Scaria A, Stepien S, Cheng AC, Edwards LJ, Robinson EJ, et al. Measuring oral COVID-19 antiviral effectiveness using linked Australian data: Challenges and opportunities. Journal of Infection and Public Health. 2026;19(7):103247. doi:10.1016/j.jiph.2026.103247
BibTeX
@article{Fathima2026,
author = {Fathima, Parveen and Scaria, Anish and Stepien, Sandrine and Cheng, Allen C and Edwards, Laura J and Robinson, Elizabeth J and Sumpton, Caroline and Amin, Janaki and Liu, Bette},
title = {Measuring oral COVID-19 antiviral effectiveness using linked Australian data: Challenges and opportunities},
journal = {Journal of Infection and Public Health},
year = {2026},
volume = {19},
number = {7},
pages = {103247},
doi = {10.1016/j.jiph.2026.103247}
}
EUVIMED